Literature DB >> 1517775

An approach to computer-aided inhibitor design: application to cathepsin L.

S Sudarsanam1, G D Virca, C J March, S Srinivasan.   

Abstract

We have developed an approach to search for molecules that can be used as lead compounds in designing an inhibitor for a given proteolytic enzyme when the 3D structure of a homologous protein is known. This approach is based on taking the cast of the binding pocket of the protease and comparing its dimensions with that of the dimensions of small molecules. Herein the 3D structure of papain is used to model cathepsin L using the comparative modeling technique. The cast of the binding pocket is computed using the crystal structure of papain because the structures of papain and the model of cathepsin L are found to be similar at the binding site. The dimensions of the cast of the binding site of papain are used to screen for molecules from the Cambridge Structural Database (CSD) of small molecules. Twenty molecules out of the 80,000 small molecules in the CSD are found to have dimensions that are accommodated by the papain binding pocket. Visual comparison of the shapes of the cast and the 20 screened molecules resulted in identifying brevotoxin b, a toxin isolated from the 'red tide' dinoflagellate Ptycho brevis (previously classified as Gymonodium breve), as the structure that best fits the binding pocket of papain. We tested the proteolytic activity of papain and cathepsin L in the presence of brevotoxin b and found inhibition of papain and cathepsin L with Kis of 25 microM and 0.6 microM, respectively. We also compare our method with a more elaborate method in the literature, by presenting our results on the computer search for inhibitors of the HIV-1 protease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517775     DOI: 10.1007/bf00123378

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  22 in total

1.  Non-inverted versus inverted plots in enzyme kinetics.

Authors:  B H HOFSTEE
Journal:  Nature       Date:  1959-10-24       Impact factor: 49.962

2.  Comparative modeling methods: application to the family of the mammalian serine proteases.

Authors:  J Greer
Journal:  Proteins       Date:  1990

3.  Amino acid sequences of the human kidney cathepsins H and L.

Authors:  A Ritonja; T Popović; M Kotnik; W Machleidt; V Turk
Journal:  FEBS Lett       Date:  1988-02-15       Impact factor: 4.124

4.  Increases in cathepsins B and L and thiol proteinase inhibitor in muscle of dystrophic hamsters. Their localization in invading phagocytes.

Authors:  E Kominami; Y Bando; K Ii; K Hizawa; N Katunuma
Journal:  J Biochem       Date:  1984-12       Impact factor: 3.387

5.  A geometric approach to macromolecule-ligand interactions.

Authors:  I D Kuntz; J M Blaney; S J Oatley; R Langridge; T E Ferrin
Journal:  J Mol Biol       Date:  1982-10-25       Impact factor: 5.469

6.  Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease.

Authors:  R L DesJarlais; G L Seibel; I D Kuntz; P S Furth; J C Alvarez; P R Ortiz de Montellano; D L DeCamp; L M Babé; C S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 7.  Cysteine proteinases and metastasis.

Authors:  B F Sloane; K V Honn
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

8.  Elastinolytic activity of human cathepsin L.

Authors:  R W Mason; D A Johnson; A J Barrett; H A Chapman
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

9.  The potential role of human kidney cortex cysteine proteinases in glomerular basement membrane degradation.

Authors:  G J Thomas; M Davies
Journal:  Biochim Biophys Acta       Date:  1989-03-24

10.  Mode of degradation of myofibrillar proteins by an endogenous protease, cathepsin L.

Authors:  U Matsukura; A Okitani; T Nishimuro; H Kato
Journal:  Biochim Biophys Acta       Date:  1981-11-13
View more
  13 in total

1.  Environmental exposures to Florida red tides: Effects on emergency room respiratory diagnoses admissions.

Authors:  Barbara Kirkpatrick; Lora E Fleming; Lorraine C Backer; Judy A Bean; Robert Tamer; Gary Kirkpatrick; Terrance Kane; Adam Wanner; Dana Dalpra; Andrew Reich; Daniel G Baden
Journal:  Harmful Algae       Date:  2006-10-01       Impact factor: 4.273

Review 2.  Transcription factor-based drug design in anticancer drug development.

Authors:  A G Papavassiliou
Journal:  Mol Med       Date:  1997-12       Impact factor: 6.354

3.  Effectors of thioredoxin reductase: Brevetoxins and manumycin-A.

Authors:  Anupama Tuladhar; Robert J Hondal; Ricardo Colon; Elyssa L Hernandez; Kathleen S Rein
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2018-11-23       Impact factor: 3.228

4.  FLOG: a system to select 'quasi-flexible' ligands complementary to a receptor of known three-dimensional structure.

Authors:  M D Miller; S K Kearsley; D J Underwood; R P Sheridan
Journal:  J Comput Aided Mol Des       Date:  1994-04       Impact factor: 3.686

5.  Review of Florida Red Tide and Human Health Effects.

Authors:  Lora E Fleming; Barbara Kirkpatrick; Lorraine C Backer; Cathy J Walsh; Kate Nierenberg; John Clark; Andrew Reich; Julie Hollenbeck; Janet Benson; Yung Sung Cheng; Jerome Naar; Richard Pierce; Andrea J Bourdelais; William M Abraham; Gary Kirkpatrick; Julia Zaias; Adam Wanner; Eliana Mendes; Stuart Shalat; Porter Hoagland; Wendy Stephan; Judy Bean; Sharon Watkins; Tainya Clarke; Margaret Byrne; Daniel G Baden
Journal:  Harmful Algae       Date:  2011-01-01       Impact factor: 4.273

6.  Literature Review of Florida Red Tide: Implications for Human Health Effects.

Authors:  Barbara Kirkpatrick; Lora E Fleming; Dominick Squicciarini; Lorrie C Backer; Richard Clark; William Abraham; Janet Benson; Yung Sung Cheng; David Johnson; Richard Pierce; Julia Zaias; Gregory D Bossart; Daniel G Baden
Journal:  Harmful Algae       Date:  2004-04-01       Impact factor: 4.273

7.  Inhalation toxicity of brevetoxin 3 in rats exposed for 5 days.

Authors:  Janet Benson; Fletcher Hahn; Thomas March; Jacob McDonald; Mohan Sopori; JeanClare Seagrave; Andrea Gomez; Andrea Bourdelais; Jerome Naar; Julia Zaias; Gregory Bossart; Daniel Baden
Journal:  J Toxicol Environ Health A       Date:  2004-09-24

8.  Drug design for ever, from hype to hope.

Authors:  G Seddon; V Lounnas; R McGuire; T van den Bergh; R P Bywater; L Oliveira; G Vriend
Journal:  J Comput Aided Mol Des       Date:  2012-01-18       Impact factor: 3.686

Review 9.  Natural and derivative brevetoxins: historical background, multiplicity, and effects.

Authors:  Daniel G Baden; Andrea J Bourdelais; Henry Jacocks; Sophie Michelliza; Jerome Naar
Journal:  Environ Health Perspect       Date:  2005-05       Impact factor: 9.031

10.  Inhalation toxicity of brevetoxin 3 in rats exposed for twenty-two days.

Authors:  Janet M Benson; Fletcher F Hahn; Thomas H March; Jacob D McDonald; Andrea P Gomez; Mohan J Sopori; Andrea J Bourdelais; Jerome Naar; Julia Zaias; Gregory D Bossart; Daniel G Baden
Journal:  Environ Health Perspect       Date:  2005-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.